Intrapartum Maternal Glycemic Control Using Insulin Pump Versus Insulin Drip - Cohort Retrospective and Prospective Observational Trial

2014-07-23 21:08:32 | BioPortfolio


The purpose of this study is to compare intrapartum glycemic control using insulin pump versus intravenous insulin administration.


the study is a cohort prospective and retrospective observational study in the tertiary center - Sheba medical center. The intrapartum glycemic control in women suffering from pregestational diabetes mellitus type 1 will be assessed using maternal capillary blood measurement. The primary outcome of the study is the number of neonatal hypoglycemic events (neonatal blood glucose < 40mg/dL). All women participating in the study will be treated according to the standard accepted protocol for "the treatment of pregestational diabetes during labor" in our institute. The research will not include new treatments or equipment.

Study Design

Observational Model: Cohort


Pregestational Diabetes


Sheba Medical Center
Ramat Gan


Not yet recruiting


Sheba Medical Center

Results (where available)

View Results


Published on BioPortfolio: 2014-07-23T21:08:32-0400

Clinical Trials [1016 Associated Clinical Trials listed on BioPortfolio]

Prediction of Fetal Lung Maturity

Diabetes is the most common medical complication of pregnancy in the united states four to five percent of pregnancies are complicated by diabetes. Pregestational diabetes (diabetes diagn...

IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes

To investigate the effect of aspirin therapy initiated in the first trimester of pregnancy in women with pregestational type I or type II diabetes on a composite clinical measure of placen...

Medical Nutrition Therapy Program for Pregnant Women With Diabetes

No dietary strategies have been designed and proved for Mexican pregnant women with diabetes. This is a randomized clinical trial of pregnant women with pregestational type 2 diabetes and ...

Glycemic Control and Iron Status in Diabetic Pregnancies - a Study of New Markers

This is an observational study at the Obstetrical outpatient clinic at Stavanger University Hospital. The main goal is to compare the current marker of glycemic control (glycated hemoglobi...

Gender Differences in Prevalence of Undiagnosed Diabetes in ACS

The primary goal of this study is to measure the prevalence of undiagnosed pre-diabetes/diabetes among women hospitalized with acute coronary syndromes (ACS) compared to men. Inpatients wi...

PubMed Articles [3902 Associated PubMed Articles listed on BioPortfolio]

Maternal diabetes alters the development of ductus venosus shunting in the fetus.

Despite adequate glycemic control, the risks of fetal macrosomia and perinatal complications are increased in diabetic pregnancies. Adjustments of the umbilical venous (UV) distribution, including inc...

Morphological and ultrasound findings in the placenta of diabetic pregnancy.

The purpose of this study is to analyze the morphological, histological, immunohistochemical and ultrasound findings in the placenta of maternal type 1 and gestational diabetes, to compare the patholo...

Diabetes in pregnancy: a new decade of challenges ahead.

Every 10 years, the Diabetic Pregnancy Study Group, a study group of the EASD, conducts an audit meeting to review the achievements of the preceding decade and to set the directions for research and ...

Long-term outcome of renal function in women with preeclampia and pregestational diabetes.

Pre-eclampsia (PE) is an important cause of acute renal failure and an important risk marker for subsequent chronic kidney disease. In normal pregnancy, there are marked changes in the renin-angiotens...

Management of Diabetes in the Intrapartum and Postpartum Patient.

Achieving maternal euglycemia in women with pregestational and gestational diabetes mellitus is critical to decreasing the risk of neonatal hypoglycemia, as maternal blood glucose levels around the ti...

Medical and Biotech [MESH] Definitions

Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).

The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).

A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy.

Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin.

More From BioPortfolio on "Intrapartum Maternal Glycemic Control Using Insulin Pump Versus Insulin Drip - Cohort Retrospective and Prospective Observational Trial"

Quick Search


Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...

Searches Linking to this Trial